Personalized breast cancer screening study at Södersjukhuset
Part of Cancer, Skin clinical trials.
This trial tests a new way to tailor breast cancer screening based on your personal risk. If you qualify, you may receive a contrast-enhanced mammogram or an automated ultrasound to find cancer earlier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 74 years old.
- You get your breast cancer screening at Södersjukhuset hospital in Stockholm.
- You have a smartphone or tablet with BankID.
- You have never had breast cancer before.
- You are not pregnant, breastfeeding, or planning to become pregnant.
- You are able to understand the study information and give your consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study offers personalized mammogram screening for women with extremely dense breasts or those who have had a false positive result. It aims to improve screening by tailoring the approach to individual risk.
This study uses a smartphone app and biological markers to predict cancer risk. It is testing whether digital and molecular data can help identify cancer earlier, especially in women with a history of certain cancers.
This trial tests whether using a robot to perform breast ultrasound can help find cancer early. You would use a smartphone to guide the screening, and the study compares this method to standard screening.
This trial tests a smartphone app called Sidekick to help women with early-stage breast cancer stick to their hormone therapy and feel more confident managing their health. If you were diagnosed with stage I, II, or III breast cancer after September 2023 and are starting hormone therapy, this program might help you stay on track.
This trial tests a program to help people at high risk for certain cancers get the free screening tests they need. It aims to make screening easier by providing personalized guidance in the community.
This study uses a special type of mammogram with contrast dye to see if it can predict how well breast cancer responds to chemotherapy before surgery. It's for people with HER2-positive or triple-negative breast cancer.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.